All lobbying filings

Brownstein Hyatt Farber Schreck, LLP

Brownstein Hyatt Farber Schreck, LLP filed a Q2 report for Eli Lilly and Company on July 20, 2026, reporting $90,000 in lobbying income.

Lobbying for Eli Lilly and Company · Pharmaceuticals

As filed: BROWNSTEIN HYATT FARBER SCHRECK, LLP for ELI LILLY AND COMPANY.

All filings by Brownstein Hyatt Farber Schreck, LLP · Everything Eli Lilly and Company has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$90,000

What the client paid this registrant for the period.

Client based in

Indiana

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Health Issues

Issues related to biotechnology legislation Diagnostic tests Clinical trial issues Issues related to supply chain

Pharmacy

Issues related to the pharmaceutical industry Treat and Reduce Obesity Act Pharmaceutical tariffs Safe Drugs Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.